Neurovision Pharma GmbH has a total of 23 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2003. It filed its patents most often in Australia, EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are SYLENTIS SA, CURNA INC and OPKO CURNA LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 4 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | United States | 3 | |
#4 | Chile | 2 | |
#5 | Israel | 2 | |
#6 | Brazil | 1 | |
#7 | China | 1 | |
#8 | Hungary | 1 | |
#9 | Republic of Korea | 1 | |
#10 | Mexico | 1 | |
#11 | Russian Federation | 1 | |
#12 | Singapore | 1 | |
#13 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Foods and drinks | |
#4 | Measurement |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Microorganisms | |
#4 | Enzymes | |
#5 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Krampert Monika | 17 |
#2 | Hossbach Markus | 17 |
#3 | Arth Hans-Lothar | 13 |
#4 | Markus Hossbach | 3 |
#5 | Monika Krampert | 3 |
#6 | Arth Hans Lothar | 2 |
#7 | Hans- Lothar Arth | 1 |
#8 | Schaebitz Wolf-Ruediger | 1 |
#9 | Gassler Nikolaus | 1 |
#10 | Schwab Stefan | 1 |
Publication | Filing date | Title |
---|---|---|
EP3050570A1 | Pharmaceutical composition consisting of a combination of G-CSF with GM-CSF | |
EP3020813A1 | Antisense-oligonucleotides as inhibitors of TGF-R signaling |